Nu SkinNUS
About: Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Employees: 11,300
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
980% more call options, than puts
Call options by funds: $324K | Put options by funds: $30K
27% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 59
8% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 40
2.87% less ownership
Funds ownership: 78.29% [Q3] → 75.41% (-2.87%) [Q4]
3% less funds holding
Funds holding: 203 [Q3] → 197 (-6) [Q4]
10% less capital invested
Capital invested by funds: $287M [Q3] → $258M (-$28.5M) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
DA Davidson Linda Bolton Weiser 30% 1-year accuracy 34 / 112 met price target | 8%downside $7 | Neutral Maintained | 20 Dec 2024 |
Financial journalist opinion
Based on 7 articles about NUS published over the past 30 days









